Moolec Science is a category creator in the alternative protein ecosystem using Molecular Farming, a disruptive technology producing animal proteins with plants.Following the closing of the Business Combination, the Combined Company's shares are expected to trade on the Nasdaq Capital Market under ticker "MLEC".Moolec Science expects to close the business combination on December 30, 2022, subject to customary closing conditions. WARWICK, United Kingdom, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Moolec Science Ltd. ("Moolec" or the "Company"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, and LightJump Acquisition Corporation (NAS

WARWICK, United Kingdom, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Moolec Science Ltd. ("Moolec Science", "Moolec"), a science-based food ingredient company focused on the use of Molecular Farming technology; and LightJump Acquisition Corp. (NASDAQ:LJAQ, "LightJump"))), a publicly traded special purpose acquisition company, today announced the filing of a registration statement on Form F-4 (the "Registration Statement") by Moolec Science SA (the "Combined Company"), which contains a preliminary proxy statement/prospectus, with the U.S. Securities and Exchange Commission ("SEC") in connection with their recently proposed business combination. While the Registration Statement, which can be found her

Sarcos Technology and Robotics Corporation ("Sarcos") (NASDAQ:STRC), a leading developer of highly dexterous robotic systems that enhance productivity, improve safety, and bring robots to unstructured and diverse environments, announces the appointment of Drew Hamer as chief financial officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221010005792/en/Sarcos Technology and Robotics Corporation Appoints Drew Hamer as Chief Financial Officer (Photo: Business Wire) Hamer is a proven finance executive with over twenty-five years of financial leadership at public and pre-public technology companies. Hamer joins Sarcos from Velodyn

WARWICK, United Kingdom, June 24, 2022 (GLOBE NEWSWIRE) -- Gastón Paladini, Co-Founder and CEO of Moolec Science Limited ("Moolec") attended the two-day Future Food-Tech Alternative Proteins Summit in New York this week, where he joined fellow industrial thought leaders, and highlighted the promise of Molecular Farming to helping address the challenge of food security. "Moolec is a science-based food ingredient company, using Molecular Farming" Paladini told the summit in his presentation ‘Molecular Farming: Producing Meat Molecules with Plants' on June 21. "We focus on scale and cost because that is the main goal: to feed the world, to feed more than 10 billion people in 2050. We are rea

Moolec Science Ltd. ("Moolec") and LightJump Acquisition Corp. ("LightJump"), a special purpose acquisition company, have entered into a definitive business combination agreement. The transaction sets Moolec's proforma equity value at $504 million, assuming no redemptions from shareholders of LightJump. Upon closing, the combined company is expected to be listed on Nasdaq under the ticker symbol "MLEC". Moolec, a science-based food ingredient company, focuses on developing real animal proteins in plants using Molecular Farming, a scalable, affordable, and sustainable technology which is the production of animal proteins using plants as small factories. The company's product portfolio and pi

LightJump Acquisition Corporation (NASDAQ:LJAQ) (the "Company") received on May 28, 2021 a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") indicating that, as a result of not having timely filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the "Form 10-Q"), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission ("SEC"). The Notice has no immediate impact on the listing of the Company's securities, which will continue to trade on Nasdaq, subject to the Company's compliance with the other continued listing requirements

SC 13G/A - LIGHTJUMP ACQUISITION CORP (0001825437) (Subject)

SC 13G - LIGHTJUMP ACQUISITION CORP (0001825437) (Subject)

SC 13G/A - LIGHTJUMP ACQUISITION CORP (0001825437) (Subject)

SC 13G/A - LIGHTJUMP ACQUISITION CORP (0001825437) (Subject)

SC 13G - LIGHTJUMP ACQUISITION CORP (0001825437) (Subject)

Southwest Air (LUV) - The airlines holiday-cancellation woes continue without end in sight. Late last week, Southwest was forced to cancel nearly 70% of its flights. Travelers remain stuck around the nation; some travelers won't be able to find new flights to their destinations til several days after the new year. Bed Bath & Beyond (BBBY) - A favorite meme stock among the retail investor crowd. Bed Bath & Beyond is expected to report its quarterly results during the second week of January. Stitch Fix (SFIX) - A play on a rumor from Tuesday. The Information speculated Amazon (AMZN) could be interested in buying Stitch Fix at

Gainers Minerva Surgical, Inc. (NASDAQ:UTRS) shares rose 166% to $0.4327 in pre-market trading after the company reported a $30 million private placement of common stock led by Accelmed Partners. Jounce Therapeutics, Inc. (NASDAQ:JNCE) rose 74.9% to $1.29 in pre-market trading after Gilead Sciences announced plans to acquire all remaining rights to the company's Immunotherapy GS-1811, an anti-CCR8 antibody, for $67 million. Kala Pharmaceuticals, Inc. (NASDAQ:KALA) shares rose 40.8% to $5.52 in pre-market trading after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal epithelial defect. Nano-X Imaging Ltd. (NASDAQ:NNOX) ro

Moolec Science Ltd. ("Moolec" or the "Company"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, and LightJump Acquisition Corporation (NASDAQ:LJAQ, ", LightJump", )))), a publicly traded special purpose acquisition company, today announced that their previously announced business combination (the "Business Combination") was approved at a special meeting of stockholders (the "Special Meeting") of LightJump on December 27, 2022. Approximately 92% of the votes cast at the Special Meeting were in favor of the Business Combination. LightJump plans to file the results of the Special Meeting, as tabulated by an independent inspector

U.S. markets opened lower on Tuesday in a truncated week after rising bond yields dragged major growth stocks and indices. The yield on the 10-year benchmark Treasury notes rose over 10 basis points to 3.858% as investors and traders began considering the possibility of a recession in 2023 and China eased its COVID-19 restrictions further. Economic releases in the U.S. indicated the advance goods trade deficit for November shrank to $83.35 billion from the previous month's $98.8 billion, while a separate report showed continued struggles for the housing market as home prices fell under rising mortgage rates, reported Reuters. Meanwhile, here are the five stocks that are drawing investors’ at

Moolec Science Ltd. ("Moolec Science", "Moolec"), a science-based food ingredient company focused on the use of Molecular Farming technology; and LightJump Acquisition Corp. (NASDAQ:LJAQ, ", LightJump", ))))), a publicly traded special purpose acquisition company, today announced the filing of a registration statement on Form F-4 (the "Registration Statement") by Moolec Science SA (the "Combined Company"), which contains a preliminary proxy statement/prospectus, with the U.S. Securities and Exchange Commission ("SEC") in connection with their recently proposed business combination. While the Registration Statement, which can be found here, has not yet become effective, and the information co

15-12G - LIGHTJUMP ACQUISITION CORP (0001825437) (Filer)

8-K - LIGHTJUMP ACQUISITION CORP (0001825437) (Filer)

8-K - LIGHTJUMP ACQUISITION CORP (0001825437) (Filer)

25-NSE - LIGHTJUMP ACQUISITION CORP (0001825437) (Subject)

8-K - LIGHTJUMP ACQUISITION CORP (0001825437) (Filer)

DEFM14A - LIGHTJUMP ACQUISITION CORP (0001825437) (Filer)

8-K - LIGHTJUMP ACQUISITION CORP (0001825437) (Filer)

10-Q - LIGHTJUMP ACQUISITION CORP (0001825437) (Filer)

8-K - LIGHTJUMP ACQUISITION CORP (0001825437) (Filer)

425 - LIGHTJUMP ACQUISITION CORP (0001825437) (Subject)